The effectiveness between the two serms is pretty much insignificant, from everything I've read. Couple points here or there. That's a whopper of a drop BB. I wonder if anything else played into it? Here's a good article on Nolva and IGF1, just disregard the breast cancer attribute. Be sure to open the chart relating to IGF-1.
Thanks Mr. BB. Please help me if I interpreted this correctly - so for males it is ineffective at fat oxidation, so per this study, a poor choice for my needs?